TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/20/24 16:15 | 12/18/24 | CLYM | Climb Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pimblett Emily | MA | O | CHIEF AC | M.d | 0 | 0.00 | 0 | 5 | 79 | 11 | D | ||||||||||||||
12/20/24 16:15 | 12/19/24 | CLYM | Climb Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pimblett Emily | MA | O | CHIEF AC | S.d | -2 | 2.02 | 0 | -1 | -10 | 11 | D | ||||||||||||||
9/20/24 21:53 | 9/18/24 | ELYM | Eliem Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pimblett Emily | DE | O | CHIEF AC | M.d | 0 | 0.00 | 0 | 5 | 195 | 8 | D | ||||||||||||||
9/20/24 21:53 | 9/20/24 | ELYM | Eliem Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pimblett Emily | DE | O | CHIEF AC | S.d | -10 | 8.18 | 0 | -1 | -14 | 8 | D | ||||||||||||||
6/21/24 14:57 | 6/18/24 | ELYM | Eliem Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pimblett Emily | DE | O | CHIEF AC | M.d | 0 | 0.00 | 0 | 5 | 4 | D | |||||||||||||||
6/21/24 14:57 | 6/20/24 | ELYM | Eliem Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Pimblett Emily | DE | O | CHIEF AC | S.d | -9 | 7.21 | 0 | -1 | -25 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |